10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na +/K +-ATPase

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In 1972 Neal Bricker presented the “trade-off” hypothesis in which he detailed the role of physiological adaptation processes in mediating some of the pathophysiology associated with declines in renal function. In the late 1990’s Xie and Askari published seminal studies indicating that the Na +/K +-ATPase (NKA) was not only an ion pump, but also a signal transducer that interacts with several signaling partners. Since this discovery, numerous studies from multiple laboratories have shown that the NKA is a central player in mediating some of these long-term “trade-offs” of the physiological adaptation processes which Bricker originally proposed in the 1970’s. In fact, NKA ligands such as cardiotonic steroids (CTS), have been shown to signal through NKA, and consequently been implicated in mediating both adaptive and maladaptive responses to volume overload such as fibrosis and oxidative stress. In this review we will emphasize the role the NKA plays in this “trade-off” with respect to CTS signaling and its implication in inflammation and fibrosis in target organs including the heart, kidney, and vasculature. As inflammation and fibrosis exhibit key roles in the pathogenesis of a number of clinical disorders such as chronic kidney disease, heart failure, atherosclerosis, obesity, preeclampsia, and aging, this review will also highlight the role of newly discovered NKA signaling partners in mediating some of these conditions.

          Related collections

          Most cited references133

          • Record: found
          • Abstract: found
          • Article: not found

          CD36 is a receptor for oxidized low density lipoprotein.

          The oxidation of low density lipoprotein (LDL) in the arterial wall is thought to contribute to human atherosclerotic lesion formation, in part by the high affinity uptake of oxidized LDL (OxLDL) by macrophages, resulting in foam cell formation. We have utilized cloning by expression to identify CD36 as a macrophage receptor for OxLDL. Transfection of a CD36 clone into 293 cells results in the specific and high affinity binding of OxLDL, followed by its internalization and degradation. An anti-CD36 antibody blocks 50% of the binding of OxLDL to platelets and to human macrophage-like THP cells. Furthermore, like mouse macrophages, 293 cells expressing CD36 recognize LDL which has been oxidized only 4 h, whereas more extensive oxidation of the LDL is required for recognition by the other known OxLDL receptors, the acetylated LDL (AcLDL) receptor and Fc gamma RII-B2. CD36 may play a role in scavenging LDL modified by oxidation and may mediate effects of OxLDL on monocytes and platelets in atherosclerotic lesions.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            CD40-CD40 ligand

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                30 August 2018
                September 2018
                : 19
                : 9
                : 2576
                Affiliations
                Department of Medicine, University of Toledo College of Medicine and Life Sciences, Health Education Building RM 205, 3000 Arlington Ave, Toledo, OH 43614, USA; kareem.khalaf@ 123456rockets.utoledo.edu (F.K.K.); prabhatchandra.dube@ 123456utoledo.edu (P.D.); amal.mohamed@ 123456rockets.utoledo.edu (A.M.); jiang.tian@ 123456utoledo.edu (J.T.); deepak.malhotra@ 123456utoledo.edu (D.M.); steven.haller@ 123456utoledo.edu (S.T.H.)
                Author notes
                [* ]Correspondence: David.Kennedy@ 123456UToledo.edu ; Fax: +1-419-383-3344
                Author information
                https://orcid.org/0000-0002-1997-0977
                https://orcid.org/0000-0002-4188-3554
                https://orcid.org/0000-0001-5265-0142
                Article
                ijms-19-02576
                10.3390/ijms19092576
                6165267
                30200235
                01b2a456-54e5-4182-88b1-126710a7ac21
                © 2018 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 09 August 2018
                : 26 August 2018
                Categories
                Review

                Molecular biology
                cardiotonic steroids,na+/k+-atpase,inflammation,fibrosis,signaling
                Molecular biology
                cardiotonic steroids, na+/k+-atpase, inflammation, fibrosis, signaling

                Comments

                Comment on this article